Cargando…
A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia
BACKGROUND: Hypophosphatasia (HPP) is a rare inherited metabolic disorder caused by mutations in the ALPL gene, which encodes tissue nonspecific alkaline phosphatase. The severity of HPP is widely diverse from the perinatal form to the adult mild form. The former represents the most severe form and...
Autores principales: | Sugiyama, Yohei, Watanabe, Taijiro, Tajika, Makiko, Matsuhashi, Tetsuro, Shimura, Masaru, Fushimi, Takuya, Ichimoto, Keiko, Matsunaga, Ayako, Ebihara, Tomohiro, Tsuruoka, Tomoko, Akiyama, Tomoyuki, Murayama, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867653/ https://www.ncbi.nlm.nih.gov/pubmed/35197081 http://dx.doi.org/10.1186/s13023-022-02230-y |
Ejemplares similares
-
Therapeutic effect of N-carbamylglutamate in CPS1 deficiency
por: Sugiyama, Yohei, et al.
Publicado: (2020) -
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
por: Orimo, Hideo
Publicado: (2016) -
Hearing impairment improved after treatment with asfotase alfa in a case of perinatal hypophosphatasia
por: Chida-Naomiya, Rie, et al.
Publicado: (2020) -
Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia
por: Pan, Wei‐Jian, et al.
Publicado: (2021) -
Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia
por: Strandbech, Olivia Sarah, et al.
Publicado: (2021)